Life Sciences: Development Strategy

Development Strategy

Life sciences companies turn to CRA when they need strategic consulting that’s tailored to the unique needs and circumstances of the development function. Our consultants have extensive experience improving performance and driving positive outcomes.

Strategic support

Asset
  • Indication prioritization based on revenue and risk
  • Development plan design and optimization
  • Trial design optimisation
Portfolio
  • Resource allocation
  • Pipeline optimization
Corporate
  • Capabilities gap analysis
  • Governance and process
  • Integration of acquisitions (capabilities)

Sample engagements

Guiding late-stage clinical development program based on payer insights
Analyzing R&D strategy and modelling portfolio implications
Commercial model re-design
Early asset development support and valuation
Ensuring a smooth ramp-up of Phase 4 program

Our life sciences practice is made up of 185 consultants that blend decades of global business experience with an extensive understanding of life sciences.

Meet our senior team >